Francisco Larrosa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francisco Larrosa has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
Alberto Codina
ENT Department, Hospital Clinic of Barcelona
4 shared publicationsJoan Remacha
ENT Department, Hospital Clinic of Barcelona
4 shared publicationsManuel Bernal-Sprekelsen
ENT Department, Hospital Clinic of Barcelona
4 shared publicationsElena Hernández-Montero
Instituto de Otologia García-Ibáñez, Barcelona, Spain
3 shared publications- Joan Remacha-Sardà
Servicio de Otorrinolaringología, Hospital Clínic de Barcelona. España
3 shared publications - Manuel Bernal-Sprekelsen
Hospital Clínic, Barcelona, Spain.
3 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1980765
Endoscopic laser-assisted approach to benign middle-ear tumors: single-center case series
Introduction: The transcanal endoscopic approach to benign middle-ear tumors allows a minimally invasive surgery, though it can be challenging. In this scenario, the laser may provide improved coagulation and vaporization, thus minimizing bleeding and trauma to the ossicular chain. The aim of this study was to report a single-center experience in the endoscopic laser-assisted approach to benign middle-ear tumors. Methods: A retrospective case series of patients who underwent exclusive transcanal endoscopic carbon dioxide (CO 2 ) or blue light (BL) laser-assisted surgery for early-stage benign middle-ear tumors between June 2018 and August 2026 was performed in a third-level, adult, university hospital. The present study expands upon a previously published case series. Results: Fifteen patients met the inclusion criteria. One case required a retroauricular incision (combined approach) and 14 cases successfully completed exclusive transcanal endoscopic excision (conversion rate 1/15, 6.7%). Out of these 14 cases, 12 patients (85.7%) were women with a mean age of 62.5 years (SD, 12.6). There were 13 glomus tympanicum (GTT) and one middle-ear adenomatous neuroendocrine tumor (MEANT). Eight GTTs were treated using a CO 2 laser and six cases (five glomus and one MEANT) using a BL laser. Mean surgical duration and hospitalization time were 150 min (range 90–230) and 9.1 h (SD, 5.9), respectively. Mean tumor size was 5.1 mm (SD, 2.1). The mean follow-up period was 43.6 months (range 3–98), with one case (7.1%) having tumor recurrence (B1 tumor). Four patients had tympanic membrane perforations repaired intraoperatively (cartilage palisade) and one patient needed myringoplasty on follow-up. Otherwise, there were no substantial postoperative complications. Mean pure-tone average improved by 5.9 dB (SD, 7.4) after surgery. This improvement was clinically limited (<10 dB). Discussion: The findings in the present study support the feasibility of endoscopic laser surgery as a minimally invasive technique for treating early-stage benign middle-ear tumors, and demonstrate favorable short- to intermediate-term clinical outcomes.
- 2 November 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1980765
Open AccessEndoscopic laser-assisted approach to benign middle-ear tumors: single-center case series
Introduction: The transcanal endoscopic approach to benign middle-ear tumors allows a minimally invasive surgery, though it can be challenging. In this scenario, the laser may provide improved coagulation and vaporization, thus minimizing bleeding and trauma to the ossicular chain. The aim of this study was to report a single-center experience in the endoscopic laser-assisted approach to benign middle-ear tumors. Methods: A retrospective case series of patients who underwent exclusive transcanal endoscopic carbon dioxide (CO 2 ) or blue light (BL) laser-assisted surgery for early-stage benign middle-ear tumors between June 2018 and August 2026 was performed in a third-level, adult, university hospital. The present study expands upon a previously published case series. Results: Fifteen patients met the inclusion criteria. One case required a retroauricular incision (combined approach) and 14 cases successfully completed exclusive transcanal endoscopic excision (conversion rate 1/15, 6.7%). Out of these 14 cases, 12 patients (85.7%) were women with a mean age of 62.5 years (SD, 12.6). There were 13 glomus tympanicum (GTT) and one middle-ear adenomatous neuroendocrine tumor (MEANT). Eight GTTs were treated using a CO 2 laser and six cases (five glomus and one MEANT) using a BL laser. Mean surgical duration and hospitalization time were 150 min (range 90–230) and 9.1 h (SD, 5.9), respectively. Mean tumor size was 5.1 mm (SD, 2.1). The mean follow-up period was 43.6 months (range 3–98), with one case (7.1%) having tumor recurrence (B1 tumor). Four patients had tympanic membrane perforations repaired intraoperatively (cartilage palisade) and one patient needed myringoplasty on follow-up. Otherwise, there were no substantial postoperative complications. Mean pure-tone average improved by 5.9 dB (SD, 7.4) after surgery. This improvement was clinically limited (<10 dB). Discussion: The findings in the present study support the feasibility of endoscopic laser surgery as a minimally invasive technique for treating early-stage benign middle-ear tumors, and demonstrate favorable short- to intermediate-term clinical outcomes.
- 2 January 2026
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 27 (1) , 53-64
Auditory toxicity of antimalarials in systemic autoimmune diseases: a systematic review and critical appraisal
Antimalarial agents, particularly hydroxychloroquine and chloroquine, are widely used in systemic autoimmune diseases. While ocular toxicity is well established, the extent and clinical relevance of potential auditory toxicity remain unclear. We conducted a systematic review to evaluate the available evidence on auditory adverse effects associated with antimalarial use in systemic autoimmune diseases. A systematic search was performed in PubMed, Scopus, and the Cochrane Library from inception to January 2025. Observational and interventional studies reporting audiological outcomes in patients exposed to antimalarials were included, excluding malaria-related treatments. Risk of bias was assessed according to study design. Due to substantial clinical and methodological heterogeneity, results were synthesized descriptively without meta-analysis. Sixteen studies encompassing heterogeneous autoimmune populations and audiological methods were included. The reported prevalence of hearing abnormalities varied widely across studies and diagnostic techniques. Associations with antimalarial exposure, dose, or duration were inconsistent. Some studies described subclinical cochlear or brainstem alterations, while others found no significant differences compared with non-exposed patients. Available evidence is limited and heterogeneous, precluding causal inferences regarding antimalarial-related auditory toxicity. Increased clinical awareness of auditory symptoms may be reasonable, but standardized monitoring is not supported. Prospective controlled studies with standardized audiological assessments are needed.
- 2 January 2026
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 27 (1) , 53-64
Auditory toxicity of antimalarials in systemic autoimmune diseases: a systematic review and critical appraisal
Antimalarial agents, particularly hydroxychloroquine and chloroquine, are widely used in systemic autoimmune diseases. While ocular toxicity is well established, the extent and clinical relevance of potential auditory toxicity remain unclear. We conducted a systematic review to evaluate the available evidence on auditory adverse effects associated with antimalarial use in systemic autoimmune diseases. A systematic search was performed in PubMed, Scopus, and the Cochrane Library from inception to January 2025. Observational and interventional studies reporting audiological outcomes in patients exposed to antimalarials were included, excluding malaria-related treatments. Risk of bias was assessed according to study design. Due to substantial clinical and methodological heterogeneity, results were synthesized descriptively without meta-analysis. Sixteen studies encompassing heterogeneous autoimmune populations and audiological methods were included. The reported prevalence of hearing abnormalities varied widely across studies and diagnostic techniques. Associations with antimalarial exposure, dose, or duration were inconsistent. Some studies described subclinical cochlear or brainstem alterations, while others found no significant differences compared with non-exposed patients. Available evidence is limited and heterogeneous, precluding causal inferences regarding antimalarial-related auditory toxicity. Increased clinical awareness of auditory symptoms may be reasonable, but standardized monitoring is not supported. Prospective controlled studies with standardized audiological assessments are needed.
- Open Access
- 24 December 2025
- Published by Ediciones Universidad de Salamanca in Revista ORL
- Vol. 16 (4) , e34201
Exoscopio 3D en cirugía otológica y de base de cráneo lateral. Revisión sistemática
Introducción y objetivo: El exoscopio 3D se ha introducido en otología y cirugía de base de cráneo como alternativa al microscopio quirúrgico, con potenciales beneficios en visualización, ergonomía y docencia. Sin embargo, la evidencia disponible continúa siendo heterogénea. El objetivo de esta revisión sistemática es sintetizar la literatura publicada sobre el uso del exoscopio en cirugía otológica y de base de cráneo lateral, con especial énfasis en su comparación con el microscopio óptico. Método: Se realizó una revisión sistemática siguiendo la declaración PRISMA 2020. Se consultaron las bases de datos PubMed y Cochrane hasta el 25 de agosto de 2025, utilizando términos MeSH y palabras clave relacionados con ear surgery, otologic surgical procedures y exoscope. Se incluyeron estudios originales en inglés o español realizados en humanos, y se excluyeron reportes de un caso, estudios en cadáveres o simulación, editoriales y estudios no originales. Resultados: De 146 registros identificados, se incluyeron 20 estudios (9 cohortes retrospectivas, 4 cohortes prospectivas y 7 series de casos), con un total de 729 pacientes: 490 operados con exoscopio y 239 con microscopio. Los procedimientos más frecuentes con exoscopio fueron implantes cocleares (42 %), cirugía de oído medio crónico (37,6 %), estapedotomías (12,7 %) y cirugía de base lateral del cráneo (7 %). Las complicaciones fueron similares entre exoscopio (3,7 %) y microscopio (5,6 %), sin diferencias significativas. Seis estudios compararon resultados auditivos sin encontrar diferencias. En ergonomía, el exoscopio mejoró de forma significativa la puntuación RULA (reducción media del 63,6 %; p < 0,001) y redujo la incidencia de dolor cervical. En calidad de imagen, se describió mayor luminosidad y campo visual más amplio en fases iniciales de implantes coclear y estapedotomía, aunque el microscopio resultó superior en campos quirúrgicos estrechos y de gran aumento. Discusión: La evidencia disponible sugiere que el exoscopio ofrece resultados quirúrgicos comparables al microscopio, con ventajas en ergonomía y docencia. La calidad de imagen se percibe superior en implantes cocleares y en fases iniciales de estapedotomía, aunque el microscopio sigue siendo más eficaz en campos estrechos y de gran aumento. Su principal aporte es la mejora ergonómica, con reducción objetiva de la carga musculoesquelética y menor dolor cervical. Limitaciones descritas incluyen menor nitidez en profundidad con pérdida de definición a grandes aumentos y un elevado coste. La curva de aprendizaje es corta, con progresiva reducción del tiempo quirúrgico. Conclusiones: El exoscopio 3D es un sistema de visualización seguro y eficaz en cirugía otológica y de base lateral de cráneo. Ofrece ventajas en ergonomía y visualización en campos abiertos, aunque no sustituye al microscopio. Además, puede representar una herramienta docente de gran utilidad.
- 24 December 2025
- Published by Ediciones Universidad de Salamanca in Revista ORL
- Vol. 16 (4) , e34201
Open AccessExoscopio 3D en cirugía otológica y de base de cráneo lateral. Revisión sistemática
Introducción y objetivo: El exoscopio 3D se ha introducido en otología y cirugía de base de cráneo como alternativa al microscopio quirúrgico, con potenciales beneficios en visualización, ergonomía y docencia. Sin embargo, la evidencia disponible continúa siendo heterogénea. El objetivo de esta revisión sistemática es sintetizar la literatura publicada sobre el uso del exoscopio en cirugía otológica y de base de cráneo lateral, con especial énfasis en su comparación con el microscopio óptico. Método: Se realizó una revisión sistemática siguiendo la declaración PRISMA 2020. Se consultaron las bases de datos PubMed y Cochrane hasta el 25 de agosto de 2025, utilizando términos MeSH y palabras clave relacionados con ear surgery, otologic surgical procedures y exoscope. Se incluyeron estudios originales en inglés o español realizados en humanos, y se excluyeron reportes de un caso, estudios en cadáveres o simulación, editoriales y estudios no originales. Resultados: De 146 registros identificados, se incluyeron 20 estudios (9 cohortes retrospectivas, 4 cohortes prospectivas y 7 series de casos), con un total de 729 pacientes: 490 operados con exoscopio y 239 con microscopio. Los procedimientos más frecuentes con exoscopio fueron implantes cocleares (42 %), cirugía de oído medio crónico (37,6 %), estapedotomías (12,7 %) y cirugía de base lateral del cráneo (7 %). Las complicaciones fueron similares entre exoscopio (3,7 %) y microscopio (5,6 %), sin diferencias significativas. Seis estudios compararon resultados auditivos sin encontrar diferencias. En ergonomía, el exoscopio mejoró de forma significativa la puntuación RULA (reducción media del 63,6 %; p < 0,001) y redujo la incidencia de dolor cervical. En calidad de imagen, se describió mayor luminosidad y campo visual más amplio en fases iniciales de implantes coclear y estapedotomía, aunque el microscopio resultó superior en campos quirúrgicos estrechos y de gran aumento. Discusión: La evidencia disponible sugiere que el exoscopio ofrece resultados quirúrgicos comparables al microscopio, con ventajas en ergonomía y docencia. La calidad de imagen se percibe superior en implantes cocleares y en fases iniciales de estapedotomía, aunque el microscopio sigue siendo más eficaz en campos estrechos y de gran aumento. Su principal aporte es la mejora ergonómica, con reducción objetiva de la carga musculoesquelética y menor dolor cervical. Limitaciones descritas incluyen menor nitidez en profundidad con pérdida de definición a grandes aumentos y un elevado coste. La curva de aprendizaje es corta, con progresiva reducción del tiempo quirúrgico. Conclusiones: El exoscopio 3D es un sistema de visualización seguro y eficaz en cirugía otológica y de base lateral de cráneo. Ofrece ventajas en ergonomía y visualización en campos abiertos, aunque no sustituye al microscopio. Además, puede representar una herramienta docente de gran utilidad.
- Open Access
- 15 November 2025
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (3) , 1507-1515
Intratympanic corticosteroid injection for Ménière’s disease: systematic review of randomized controlled trials
Introduction: Menière’s disease is a chronic inner ear disorder marked by episodic vertigo, tinnitus, fluctuating sensorineural hearing loss, and aural fullness, all of which significantly impair quality of life. Intratympanic corticosteroids (ITCs) have emerged as a potential therapy, but their clinical efficacy and safety remain uncertain. Methods: A systematic review was conducted of randomized controlled trials (RCTs) comparing ITC to placebo in adult MD patients. Comprehensive searches were performed across multiple electronic databases. Six RCTs met the inclusion criteria, evaluating formulations such as dexamethasone and the sustained-release OTO-104. Outcomes were synthesized narratively, and the certainty of evidence was assessed using the GRADE framework. Results: Evidence for the primary outcome—vertigo control—was rated as low certainty, due to methodological heterogeneity, inconsistent findings, and imprecision. Two trials demonstrated significant improvements with ITC compared to placebo, but results were not consistent across studies. Evidence for secondary outcomes, including tinnitus and aural pressure, was of very low to low certainty. Safety outcomes were supported by moderate-certainty evidence, with no serious adverse events reported across studies. Conclusions: This review highlights the persistent uncertainty surrounding the clinical effectiveness of ITCs in MD. While some evidence supports modest benefit for vertigo control, inconsistencies and low certainty limit generalizability. Future RCTs should prioritize standardized outcome measures and robust methodological design to better define the therapeutic role of ITCs in Menière´s disease.MD.
- 15 November 2025
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (3) , 1507-1515
Open AccessIntratympanic corticosteroid injection for Ménière’s disease: systematic review of randomized controlled trials
Introduction: Menière’s disease is a chronic inner ear disorder marked by episodic vertigo, tinnitus, fluctuating sensorineural hearing loss, and aural fullness, all of which significantly impair quality of life. Intratympanic corticosteroids (ITCs) have emerged as a potential therapy, but their clinical efficacy and safety remain uncertain. Methods: A systematic review was conducted of randomized controlled trials (RCTs) comparing ITC to placebo in adult MD patients. Comprehensive searches were performed across multiple electronic databases. Six RCTs met the inclusion criteria, evaluating formulations such as dexamethasone and the sustained-release OTO-104. Outcomes were synthesized narratively, and the certainty of evidence was assessed using the GRADE framework. Results: Evidence for the primary outcome—vertigo control—was rated as low certainty, due to methodological heterogeneity, inconsistent findings, and imprecision. Two trials demonstrated significant improvements with ITC compared to placebo, but results were not consistent across studies. Evidence for secondary outcomes, including tinnitus and aural pressure, was of very low to low certainty. Safety outcomes were supported by moderate-certainty evidence, with no serious adverse events reported across studies. Conclusions: This review highlights the persistent uncertainty surrounding the clinical effectiveness of ITCs in MD. While some evidence supports modest benefit for vertigo control, inconsistencies and low certainty limit generalizability. Future RCTs should prioritize standardized outcome measures and robust methodological design to better define the therapeutic role of ITCs in Menière´s disease.MD.
- Open Access
- 12 September 2025
- Published by Ediciones Universidad de Salamanca in Revista ORL
- Vol. 16 (4) , e33102
Exoscopio 3D para la descompresión del nervio facial después de fractura del hueso temporal: informe de caso
Introducción: Las fracturas del hueso temporal pueden asociarse a parálisis del nervio facial, complicación que requiere intervención especializada. Tradicionalmente, la visualización se realiza con microscopio o endoscopio; sin embargo, el exoscopio 3D es una tecnología emergente en cirugía otológica. Objetivo: Presentar el primer caso documentado de descompresión del nervio facial tras fractura de hueso temporal utilizando un exoscopio 3D como sistema de visualización. Descripción del caso: Mujer de 70 años con parálisis facial izquierda diferida tras fractura longitudinal del hueso temporal. Ante fracaso del tratamiento conservador y evidencia de degeneración neural superior al 90 % en electroneurografía, se realizó descompresión quirúrgica de la tercera porción del nervio mediante abordaje transmastoideo y uso de exoscopio 3D. La cirugía permitió la preservación de la audición y la integridad de la cadena osicular. La paciente experimentó recuperación funcional progresiva, alcanzando la movilidad facial completa a los dos meses postoperatorios. Conclusiones: El exoscopio 3D mostró excelente calidad de imagen y ergonomía, facilitando la precisión de la descompresión del nervio facial. Esta técnica representa una alternativa prometedora para mejorar los resultados en casos de parálisis facial secundaria a fractura del hueso temporal.
- 12 September 2025
- Published by Ediciones Universidad de Salamanca in Revista ORL
- Vol. 16 (4) , e33102
Open AccessExoscopio 3D para la descompresión del nervio facial después de fractura del hueso temporal: informe de caso
Introducción: Las fracturas del hueso temporal pueden asociarse a parálisis del nervio facial, complicación que requiere intervención especializada. Tradicionalmente, la visualización se realiza con microscopio o endoscopio; sin embargo, el exoscopio 3D es una tecnología emergente en cirugía otológica. Objetivo: Presentar el primer caso documentado de descompresión del nervio facial tras fractura de hueso temporal utilizando un exoscopio 3D como sistema de visualización. Descripción del caso: Mujer de 70 años con parálisis facial izquierda diferida tras fractura longitudinal del hueso temporal. Ante fracaso del tratamiento conservador y evidencia de degeneración neural superior al 90 % en electroneurografía, se realizó descompresión quirúrgica de la tercera porción del nervio mediante abordaje transmastoideo y uso de exoscopio 3D. La cirugía permitió la preservación de la audición y la integridad de la cadena osicular. La paciente experimentó recuperación funcional progresiva, alcanzando la movilidad facial completa a los dos meses postoperatorios. Conclusiones: El exoscopio 3D mostró excelente calidad de imagen y ergonomía, facilitando la precisión de la descompresión del nervio facial. Esta técnica representa una alternativa prometedora para mejorar los resultados en casos de parálisis facial secundaria a fractura del hueso temporal.
- Open Access
- 8 October 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (5) , e70019
Current approaches to facial nerve schwannoma surgery
Background: Facial nerve schwannomas (FNSs) are exceedingly rare benign tumors. This study aims to report on a series of excised FNSs, providing clinical information and details on their surgical management, including novel approaches.Methods: We retrospectively reviewed patients who underwent surgical excision of FNSs in a private otology clinic and public tertiary referral center. The main outcome measures were facial nerve function, complete tumor removal, postoperative complications, tumor recurrence, and hearing.Results: Seventeen patients (10 men and 7 women) with a mean age of 44.23 years (SD, 12.21) underwent surgery during the study period. The most common symptom was facial nerve dysfunction (58.8%). Facial and otoneurologic symptoms (hearing loss, tinnitus, and vertigo) were observed in 88.8% and 77.7% of patients, respectively. The middle cranial fossa (MCF) was the most common approach (six patients, 35.2%), followed by translabyrinthine (TL), transmastoid (TM), and combined TM‐MCF (three patients, 17.6% each). Exclusive endoscopic transcanal suprageniculate (ETS) and mastoid combined with cervical approaches were applied once in two patients, 5.8% each. Total tumor removal was achieved in all cases. No significant postoperative complications were observed. The mean follow‐up period was 193.2 months (SD, 119.5) and no tumor recurrence was observed.Conclusion: This study provides further evidence for the safety and efficacy of various surgical approaches for FNS, and incorporates the endoscopic transcanal approach.Level of evidence: 4.
- 8 October 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (5) , e70019
Open AccessCurrent approaches to facial nerve schwannoma surgery
Background: Facial nerve schwannomas (FNSs) are exceedingly rare benign tumors. This study aims to report on a series of excised FNSs, providing clinical information and details on their surgical management, including novel approaches.Methods: We retrospectively reviewed patients who underwent surgical excision of FNSs in a private otology clinic and public tertiary referral center. The main outcome measures were facial nerve function, complete tumor removal, postoperative complications, tumor recurrence, and hearing.Results: Seventeen patients (10 men and 7 women) with a mean age of 44.23 years (SD, 12.21) underwent surgery during the study period. The most common symptom was facial nerve dysfunction (58.8%). Facial and otoneurologic symptoms (hearing loss, tinnitus, and vertigo) were observed in 88.8% and 77.7% of patients, respectively. The middle cranial fossa (MCF) was the most common approach (six patients, 35.2%), followed by translabyrinthine (TL), transmastoid (TM), and combined TM‐MCF (three patients, 17.6% each). Exclusive endoscopic transcanal suprageniculate (ETS) and mastoid combined with cervical approaches were applied once in two patients, 5.8% each. Total tumor removal was achieved in all cases. No significant postoperative complications were observed. The mean follow‐up period was 193.2 months (SD, 119.5) and no tumor recurrence was observed.Conclusion: This study provides further evidence for the safety and efficacy of various surgical approaches for FNS, and incorporates the endoscopic transcanal approach.Level of evidence: 4.
- Open Access
- 9 February 2024
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 281 (4) , 2041-2045
Blue laser for the exclusive endoscopic transcanal approach to middle ear paraganglioma
Background: The management of glomus tympanicum tumours can be challenging. Blue laser coagulation may improve bleeding control thus facilitating an endoscopic transcanal excision. The objective of this presentation is to illustrate the authors’ experience using this novel tool. Methods: Case report of a patient that underwent exclusive endoscopic transcanal blue laser surgery of a class A2 glomus tympanicum tumour in a tertiary referral center. Conclusion: The present study provides evidence of the safety and efficacy of endoscopic blue laser surgery, for the minimally invasive treatment of early-stage glomus tympanicum tumours.
- 9 February 2024
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 281 (4) , 2041-2045
Open AccessBlue laser for the exclusive endoscopic transcanal approach to middle ear paraganglioma
Background: The management of glomus tympanicum tumours can be challenging. Blue laser coagulation may improve bleeding control thus facilitating an endoscopic transcanal excision. The objective of this presentation is to illustrate the authors’ experience using this novel tool. Methods: Case report of a patient that underwent exclusive endoscopic transcanal blue laser surgery of a class A2 glomus tympanicum tumour in a tertiary referral center. Conclusion: The present study provides evidence of the safety and efficacy of endoscopic blue laser surgery, for the minimally invasive treatment of early-stage glomus tympanicum tumours.